News Releases

The University of Pennsylvania Health System has formed a joint venture with Nashville-based Evergreen Nephrology to improve care for patients with chronic and end-stage kidney disease while containing costs through innovative approaches to provide more care, including dialysis, at home, reduce the need for emergency department visits and hospitalizations, and get kidney transplants sooner.

With an $8 million grant from the National Institutes of Health (NIH), the next stage of the THINKER project, THINKER-NEXT, will aim to provide a show the risks and benefits of transplanting HCV-infected kidneys into non-infected patients.

Two genetic risk variants that are carried by nearly 40 percent of Black individuals may exacerbate the severity of both sepsis and COVID-19, a team of researchers from the University of Pennsylvania’s Perelman School of Medicine have found.

Despite impacting an estimated 850 million people and being responsible for 1 in 60 deaths worldwide, few treatments are available for chronic kidney disease. Understanding the genetic variations associated with the disease represents an important step for drug development.